Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Lunit Joins as an Associate Partner with the World Economic Forum 2023-10-31 21:00
YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine 2023-10-31 20:30
Meihua International Medical Technologies Co., Ltd. Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device Technologies to China and Hainan Free Trade Port Boao Hope City 2023-10-31 20:00
iba 2023: Angel Yeast brings latest baking products and solutions, empowering the China team to triumph in the iba.UIBC.Cup of Bakers 2023-10-31 20:00
HOYA Vision Care Releases One-Year MiYOSMART European Study Results 2023-10-31 19:13
CHIMERIC THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR CHM 2101, A NOVEL CDH17 CAR T CELL THERAPY FOR ADVANCED GASTROINTESTINAL CANCERS 2023-10-31 19:00
Select the Right Medical-Grade TPU:ICP DAS - BMP Launches a New TPU Series at COMPAMED & IPF Japan 2023 2023-10-31 16:38
Osteopathy Australia and Exercise & Sports Science Australia express profound disappointment in the tokenistic NDIS (National Disability Insurance Scheme) review process 2023-10-31 15:57
TCI Unveils Revolutionary Weight Loss Formula at SupplySide West 2023 - Human Trials Showcase Remarkable Effectiveness in Just 14 Days! 2023-10-31 15:54
Biotechnology Start-Up Psylo Wins Hello Tomorrow APAC Deep Tech Competition in Singapore 2023-10-31 15:42
Embrace Exquisite Living with Innovative Personal Care Products at the 134th Canton Fair 2023-10-31 15:17
iNtRON, Executes Evaluation License and Option Agreement for SAL200 2023-10-31 12:20
Chula's Faculty of Allied Health Sciences Promotes "46 Recipes to Train Swallowing" in Elderly and Troubled Patients 2023-10-31 10:51
CStone Announces NMPA Approval of Sugemalimab for Patients with Relapsed or Refractory Extranodal NK/T-cell Lymphoma, the First Anti-PD-1/PD-L1 mAb Approved for this Indication 2023-10-31 10:16
AffaMed Therapeutics Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery 2023-10-31 09:35
SK Life Science Labs, a Subsidiary of SK Biopharmaceuticals, Presents Discovery of Oral SMARCA2 Degraders Data at 6th Annual Targeted Protein Degradation Summit 2023-10-31 08:00
Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-207 in EGFR-Mutant NSCLC 2023-10-31 07:00
LifeSpan Vision Ventures Invests in NaNotics 2023-10-31 02:26
Pulsecare Medical's nsPFA clinical trial receives satisfactory short-term follow-up results 2023-10-30 23:02
AIRS Medical Accelerates Global Expansion, Showcasing clinical achievements of MRI Enhancement Solution at RSNA 2023 2023-10-30 23:00
1 172 173 174 175 176 1619